Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gout.

John D FitzGerald1

  • 1University of California, Los Angeles, Los Angeles, California (J.D.F.).

Annals of Internal Medicine
|March 10, 2025
PubMed
Summary
This summary is machine-generated.

Gout, a common inflammatory arthritis, involves monosodium urate crystal buildup. Lowering urate levels below saturation is key to preventing painful flares and joint damage, despite available treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A bioinspired microfluidic wearable sensor for multiday sweat sampling, transport, and metabolic analysis.

Science advances·2025
Same author

The Risk of Cardiovascular Disease among Male and Female Participants Treated for Gout in the Multi-Ethnic Study of Atherosclerosis (MESA).

Gout, urate, and crystal deposition disease·2025
Same author

The Design of a Randomized Controlled Active Comparator Strategy Trial for Gout: Treat to Target Serum Urate Versus Treat to Avoid Symptoms.

ACR open rheumatology·2025
Same author

Use and safety of corticosteroid injections in joints and musculoskeletal soft tissue: guidelines from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, the American Society of Interventional Pain Physicians, and the International Pain and Spine Intervention Society.

Regional anesthesia and pain medicine·2025
Same author

A Novel Polarized Light Microscope for the Examination of Birefringent Crystals in Synovial Fluid.

Gout, urate, and crystal deposition disease·2025
Same author

Development of gout in people with asymptomatic hyperuricemia: study protocol for a 5-year prospective cohort.

BMJ open·2024
Same journal

Correction to I.M. Matters News: Sleep medicine for seniors.

Annals of internal medicine·2026
Same journal

Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone : A Target Trial Emulation.

Annals of internal medicine·2026
Same journal

Leveraging Real-World Evidence to Inform Regulatory, Clinical, and Coverage Decisions Related to Glucagon-Like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Annals of internal medicine·2026
Same journal

Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Annals of internal medicine·2026
Same journal

Weekly and Biweekly Treatment With Bofanglutide Versus Semaglutide in Chinese Patients With Type 2 Diabetes : A Phase 2b Randomized Clinical Trial.

Annals of internal medicine·2026
Same journal

Grappling with GLP-1 prescribing.

Annals of internal medicine·2026
See all related articles

Area of Science:

  • Rheumatology
  • Crystal-induced arthritis
  • Metabolic bone disease

Background:

  • Gout is the most prevalent inflammatory arthritis, affecting over 12 million US adults.
  • Characterized by monosodium urate (MSU) crystal deposition in joints and tissues, leading to painful flares and damage.
  • Hyperuricemia, with serum urate levels exceeding 6.8 mg/dL, promotes MSU crystal formation and growth.

Purpose of the Study:

  • To underscore the critical role of lowering serum urate levels below the saturation threshold.
  • To highlight the established pathophysiology and availability of effective gout therapies.
  • To address the suboptimal patient outcomes despite current management strategies.

Main Methods:

  • Review of gout pathophysiology and current treatment paradigms.

Related Experiment Videos

  • Analysis of urate solubility thresholds and crystal formation mechanisms.
  • Evaluation of treatment efficacy in preventing flares and tissue damage.

    • Main Results:

    • Reducing serum urate levels below 6.8 mg/dL is the primary strategy for gout management.
    • Effective and affordable therapies exist to lower urate levels.
    • Despite available treatments, patient outcomes in gout remain suboptimal.

    Conclusions:

    • Achieving and maintaining serum urate levels below saturation is essential for preventing gout flares, tophi, and chronic joint damage.
    • The gap between treatment availability and optimized patient outcomes necessitates further investigation and improved management approaches.
    • Understanding gout pathophysiology is crucial for effective long-term disease control.